Expression linked and R-ISS Adapted therapy Stratification for first line therapy in multiple myeloma patients (ELIAS)

Basic data for this project

Type of project: Individual project

Duration at the University of Münster: 09/04/2020 - 31/12/2028

Description

Keywords: Newly diagnosed multiple myeloma; Clinical trial

Website of the project: https://www.medizin.uni-muenster.de/ibkf/forschung/medizinische-forschungsprojekte/elias.html

Funding identifier: SSA_2021_047578

Funder / funding scheme:

Sanofi-Aventis (Germany)

Project management at the University of Münster

Khandanpour, Cyrus

Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)

Applicants from the University of Münster

Khandanpour, Cyrus

Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)

Research associates from the University of Münster

Institute of Biostatistics and Clinical Research (IBKF)

Project partners outside the University of Münster

Sanofi-Aventis Deutschland GmbHGermany